DOA
WST icon

D'Orazio & Associates’s West Pharmaceutical WST Stock Holding History

D'Orazio & Associates’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-39
Closed -$17K – 719
2021
Q3 		$17K Buy
+39
New +$16.4K ﹤0.01% 447

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

D'Orazio & Associates's WST Position: Q4 2021 in Review

D'Orazio & Associates sold out of West Pharmaceutical (WST) in Q4 2021, closing a stake of 39 shares — an estimated $17K sold.

D'Orazio & Associates first reported a position in WST in Q3 2021 and held it in 1 quarter. The position peaked at $17K in Q3 2021. 730 funds tracked by Wall St. Rank hold WST as of Q4 2021.

  • D'Orazio & Associates reported no remaining West Pharmaceutical position as of Q4 2021 after selling out during the quarter.
  • D'Orazio & Associates sold 39 West Pharmaceutical shares in Q4 2021, an estimated $17K.
  • D'Orazio & Associates first reported a position in West Pharmaceutical in Q3 2021 and held it in 1 quarter.
  • D'Orazio & Associates's West Pharmaceutical position peaked at $17K in Q3 2021.
  • 730 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2021.

Based on D'Orazio & Associates's 13F filing for Q4 2021, filed 7 Feb 2022.